1360616-38-1 Usage
Description
(4-(oxazol-5-yl)phenyl)methanamine trifluoroacetate is a complex organic compound that features a phenyl ring with an oxazol ring attached to it, connected to a methanamine group. The oxazol ring is a five-membered heterocyclic ring containing oxygen and nitrogen atoms, while the trifluoroacetate group is a salt derived from trifluoroacetic acid, containing three fluorine atoms. (4-(oxazol-5-yl)phenyl)methanamine trifluoroacetate may have potential applications in pharmaceuticals or organic synthesis due to the presence of the phenyl and oxazol groups, which are common in biologically active compounds. Additionally, the trifluoroacetate group can enhance the solubility and stability of the compound.
Uses
Used in Pharmaceutical Industry:
(4-(oxazol-5-yl)phenyl)methanamine trifluoroacetate is used as a building block for the synthesis of biologically active compounds due to the presence of the phenyl and oxazol groups, which are common in pharmaceuticals. Its unique structure may contribute to the development of new drugs with specific therapeutic properties.
Used in Organic Synthesis:
(4-(oxazol-5-yl)phenyl)methanamine trifluoroacetate is used as an intermediate in the synthesis of various organic compounds. Its versatile structure allows for further functionalization and modification, making it a valuable component in the creation of complex organic molecules.
Used in Enhancing Solubility and Stability:
(4-(oxazol-5-yl)phenyl)methanamine trifluoroacetate is used to improve the solubility and stability of other compounds in pharmaceutical formulations. The trifluoroacetate group can increase the compound's solubility in water, which is essential for drug delivery and absorption.
Check Digit Verification of cas no
The CAS Registry Mumber 1360616-38-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,6,0,6,1 and 6 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1360616-38:
(9*1)+(8*3)+(7*6)+(6*0)+(5*6)+(4*1)+(3*6)+(2*3)+(1*8)=141
141 % 10 = 1
So 1360616-38-1 is a valid CAS Registry Number.
1360616-38-1Relevant articles and documents
COMPOUNDS AND METHODS FOR THE INHIBITION OF VCB E3 UBIQUITIN LIGASE
-
, (2013/07/25)
The present invention relates to novel compounds which find utility as modulators, especially inhibitors of VCB E3 Ubiquitin Ligase and as bioactive agents for use as therapeutics for the stimulation of erythropoiesis in a patient or subject including inducement of EPO production in the patient or subject, for the treatment of chronic anemia and ischemia (limits brain injury during episodes of localized anemia, ischemia and/or stroke and damage to cardiovascular tissue during cardiovascular ischemia), as well as enhancing wound healing processes. Pharmaceutical compositions comprising effective amounts of compounds according to the present invention alone or in combination with an additional erythropoieses stimulating agent such as EPO under the tradename procrit or epogen or darbapoietin alfa under the tradename aranesp. Methods of stimulating erythropoiesis in a subject or patient, including increasing the number of red blood cells and/or hematocrit of the patient, treating anemia, including chronic anemia and anemia associated with chronic kidney disease, dialysis, and cancer chemotherapy, ischemia, stroke and damage to cardiovascular tissue during cardiovascular ischemia as well as enhancing wound healing processes and preventing/reducing scarring secondary to healing represent additional aspects of the present invention. Local enhancement of angiogenesis through induction of VEGF including wound healing and reduction of stent occlusion remain additional aspects of the present invention.
